<DOC>
	<DOCNO>NCT01713335</DOCNO>
	<brief_summary>The aim study evaluate kallikreins substrate , CCN , COPD patient . Kallikreins subgroup serine protease , enzyme able cleave peptide bond protein . Kallicrein profile unkonwn COPD . The investigator assess Kallikrein 1 15 CCN 1 6 sputum patient . Three group patient include : Healthy smoker subject , stable COPD patient COPD patient acute exacerbation . Kallicrein level sputum compare group .</brief_summary>
	<brief_title>Proteasis Evaluation COPD</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Inclusion Criteria healthy subject : Smoker tobacco consumption 20 pack/year Normal lung function test Exclusion Criteria healthy subject : diagnosis lung disease study Asthma Lung cancer Pregnant lactate woman Inclusion Criteria stable COPD : Smoker tobacco consumption 20 pack/year FEV1/FVC &lt; 70 % lung function test hospitalisation exacerbation 3 month inclusion Exclusion Criteria stable COPD : Asthma Lung cancer Pregnant lactate woman Inclusion Criteria COPD exacerbation : Smoker tobacco consumption 20 pack/year worsen pulmonary symptom FEV1/FVC &lt; 70 % lung function test could obtain 3 month exacerbation Exclusion Criteria COPD exacerbation : Asthma Lung cancer Pregnant lactate woman</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>